Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 10:53 PM UTC
| NCT Number | NCT06892522 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | Clinical Trial |
| Target Enrollment | 440 participants |
| Active Locations | 2 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | February 17, 2026 (Feb 17, 2026) |
As of April 17, 2026: Clinical trial NCT06892522 is currently recruiting participants. This clinical trial study for multiple myeloma is actively seeking new participants at 2 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06892522 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06892522 was last updated Feb 17, 2026 (February 17, 2026). HelloStudys verifies this status automatically.